(Spry, 2013) and What Being the Parent of a Baby is Like Questionnaire (Pridham & Chang, 1989) were worded such that they would have had explicit relevance to parents in the early part of the study, and they were retained across the 24 month period to allow for longitudinal comparison. ...
PARPis, such as olaparib and talazoparib, have shown significant improvements in progression-free survival (PFS) among patients with germline BRCA1/2-mutated metastatic breast cancer (BC), as evidenced by the OlympiAD and EMBRACA Phase III trials. However, these trials did not demonstrate a sign...
Vaccinated patients had a 3-year recurrence-free survival of 87.5% (95% CI 72.7–100%) compared to 49% (95% CI 36.4–65.9%) in the control. It is important to recognize the limitations of comparison to historical controls. Important limitations include selection bias in the trial enrollment...
Data from the LocoMMotion study are a valuable benchmark for comparison with newly approved and emerging therapies [15]. The prospective design, comprehensive data collection, and the completeness of the baseline characteristics data allow for comparative analyses with other single-arm trials in this ...
9C). In addition, G-CSF was elevated in the combination treatment (p = 0.0314) and carbo/pax (p = 0.0148) groups in comparison to IgG isotype controls (Fig. 9D). G-CSF is a proinflammatory cytokine that stimulates the production of myeloid immune cells and is commonly used as...
In the comparison study between the ECNPs and its sol- uble combination form at the third dose, curcumin and efavirenz were found to be approx. 30 ng/ml & 20 ng/ml and 44 ng/ml & 35 ng/ml respectively, suggest that at higher doses also the NPs could me marked as safe....
(anti-human, pure-functional grade, clone OKT3, Miltenyi Biotec, Bergisch Gladbach, Germany) and anti-CD28 antibody (anti-human, pure-functional grade, clone 15E8, Miltenyi Biotec, Bergisch Gladbach, Germany)) were used in comparison to those of activated T cells treated with single peptide, ...
Comparison of prognostic value between the MLIIC signature and previous signatures In the TCGA dataset, the MLIIC signature was markedly related to survival status, tumor stage, and TNM staging system (Fig. 3A). Besides, the MLIIC signature indicated the prognostic potential for superior accuracy ...
Subsequently, the statistical analysis was performed by one-way ANOVA followed, where applicable, by Tukey’s multiple comparison test. The differences between the groups where found to be not significantly different for EA.hy926 (P = 0.1863) and for HMEC-1 (P = 0.1774). The ...
Comparison of prognostic value between the MLIIC signature and previous signatures In the TCGA dataset, the MLIIC signature was markedly related to survival status, tumor stage, and TNM staging system (Fig. 3A). Besides, the MLIIC signature indicated the prognostic potential for superior accuracy ...